Characteristics of the Protective Subcellular Coccidioidal T27K Vaccine
- 1 September 2007
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1111 (1) , 275-289
Abstract
While the whole killed spherule vaccine, protective in mice and monkeys, did not prevent coccidioidal disease in humans, the 27K vaccine, a soluble derivative, retains protective activity in mice with little irritant action. Gel filtration and anion exchange fractions of thimerosal‐inactivated spherules (T27K), when administered with alum adjuvant, also protect mice against lethal respiratory coccidioidal challenge. However, the superb protection afforded by T27K antigens is maintained for some 3 months, but may then diminish. This appears unrelated to the aging of the mice. Prolongation of the protective action may require addition of a different adjuvant or administration of booster doses of vaccine.Keywords
This publication has 17 references indexed in Scilit:
- Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single proteinVaccine, 2006
- A Recombinant Aspartyl Protease ofCoccidioides posadasiiInduces Protection against Pulmonary Coccidioidomycosis in MiceInfection and Immunity, 2006
- Intradermal Influenza Vaccination — Can Less Be More?New England Journal of Medicine, 2004
- Role of Signal Sequence in Vaccine-Induced Protection against Experimental CoccidioidomycosisInfection and Immunity, 2002
- Seeking a Vaccine against Coccidioides immitis and Serologic Studies: Expectations and RealitiesFungal Genetics and Biology, 2001
- Coccidioides immitisAntigenThe Journal of Infectious Diseases, 1999
- Evaluation of the Protective Efficacy of the Killed Coccidioides immitis Spherule Vaccine in HumansAmerican Review of Respiratory Disease, 1993
- A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature.American Journal of Public Health, 1979
- THE PRESENT STATUS OF VACCINATION AGAINST COCCIDIOIDOMYCOSIS IN MANAmerican Journal of Epidemiology, 1975
- COMPARISON OF INTRADERMAL AND SUBCUTANEOUS ROUTES OF CHOLERA VACCINE ADMINISTRATIONThe Lancet, 1972